drugset

drugset / Trial / NCT00298701

Tolerability of Grazax-R in Children

NCT00298701 ↗

Phase 1 Completed 50 enrolled ALK-Abelló A/S

RandomizedParallel-groupDouble-blind

Summary

This trial is performed to assess whether the Grazax-R treatment is safe to use in children aged 5-12 years.

Timeline

Start: 2006-02
Primary completion: —
Completion: 2006-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GRAZAX-R	Unknown	—	—

Indications